Alina L. Boteanu-rekin lankidetzan egindako argitalpenak (4)

2023

  1. What drives the decision to optimise biological treatment in children and youngsters with juvenile idiopathic arthritis? A discrete-choice experiment

    Reumatologia Clinica, Vol. 19, Núm. 1, pp. 26-33

2020

  1. Opportunistic infections in immunosuppressed patients with juvenile idiopathic arthritis: Analysis by the Pharmachild Safety Adjudication Committee

    Arthritis Research and Therapy, Vol. 22, Núm. 1

2019

  1. Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study

    The Lancet Child and Adolescent Health, Vol. 3, Núm. 4, pp. 255-263

2018

  1. The Castilian Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)

    Rheumatology International, Vol. 38, pp. 91-98